HALOZYME THERAPEUTICS, INC. Income Tax Expense
HALOZYME THERAPEUTICS, INC. (HALO) reported Income Tax Expense of $54.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- HALOZYME THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $54.99M, a 38.24% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $30.28M, a 17.66% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $40.74M, a 1.12% decline year-over-year.
- HALOZYME THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was $43.73M, a 55.43% increase year-over-year.
- HALOZYME THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2025 was $149.99M, a 32.68% increase from fiscal 2024.
- HALOZYME THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2024 was $113.04M, a 69.39% increase from fiscal 2023.
- HALOZYME THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2023 was $66.73M, a 42.63% increase from fiscal 2022.
- HALOZYME THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2022 was $46.79M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $54.99M 10-Q · filed 2026-08-06 | $85.27M 10-Q · filed 2026-08-06 | $126.01M derived: sum of 3 quarters · filed 2026-08-06 | $169.74M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $30.28M 10-Q · filed 2026-05-11 | $71.02M derived: sum of 2 quarters · filed 2026-05-11 | $114.75M derived: sum of 3 quarters · filed 2026-05-11 | $154.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $40.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $84.47M derived: sum of 2 quarters · filed 2026-02-17 | $124.25M derived: sum of 3 quarters · filed 2026-08-06 | $149.99M 10-K · filed 2026-02-17 |
| 2025-09-30 | $43.73M 10-Q · filed 2025-11-03 | $83.51M derived: sum of 2 quarters · filed 2026-08-06 | $109.24M 10-Q · filed 2025-11-03 | $150.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $39.78M 10-Q · filed 2026-08-06 | $65.51M 10-Q · filed 2026-08-06 | $106.71M derived: sum of 3 quarters · filed 2026-08-06 | $134.85M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $25.73M 10-Q · filed 2026-05-11 | $66.94M derived: sum of 2 quarters · filed 2026-05-11 | $95.07M derived: sum of 3 quarters · filed 2026-05-11 | $119.57M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $41.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $69.34M derived: sum of 2 quarters · filed 2026-02-17 | $93.84M derived: sum of 3 quarters · filed 2026-02-17 | $113.04M 10-K · filed 2026-02-17 |
| 2024-09-30 | $28.14M 10-Q · filed 2025-11-03 | $52.63M derived: sum of 2 quarters · filed 2025-11-03 | $71.84M 10-Q · filed 2025-11-03 | $87.63M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $24.50M 10-Q · filed 2025-08-05 | $43.70M 10-Q · filed 2025-08-05 | $59.49M derived: sum of 3 quarters · filed 2026-02-17 | $79.41M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $19.20M 10-Q · filed 2025-05-06 | $34.99M derived: sum of 2 quarters · filed 2026-02-17 | $54.91M derived: sum of 3 quarters · filed 2026-02-17 | $73.32M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $15.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $35.71M derived: sum of 2 quarters · filed 2026-02-17 | $54.11M derived: sum of 3 quarters · filed 2026-02-17 | $66.73M 10-K · filed 2026-02-17 |
| 2023-09-30 | $19.92M 10-Q · filed 2024-10-31 | $38.33M derived: sum of 2 quarters · filed 2024-10-31 | $50.95M 10-Q · filed 2024-10-31 | $64.04M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $18.40M 10-Q · filed 2024-08-06 | $31.02M 10-Q · filed 2024-08-06 | $44.11M derived: sum of 3 quarters · filed 2025-02-18 | $56.19M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $12.62M 10-Q · filed 2024-05-07 | $25.71M derived: sum of 2 quarters · filed 2025-02-18 | $37.78M derived: sum of 3 quarters · filed 2025-02-18 | $45.11M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $13.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $25.16M derived: sum of 2 quarters · filed 2025-02-18 | $32.49M derived: sum of 3 quarters · filed 2025-02-18 | $46.79M 10-K · filed 2025-02-18 |
| 2022-09-30 | $12.07M 10-Q · filed 2023-11-06 | $19.40M derived: sum of 2 quarters · filed 2023-11-06 | $33.70M 10-Q · filed 2023-11-06 | $21.74M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | $7.33M 10-Q · filed 2023-08-08 | $21.63M 10-Q · filed 2023-08-08 | $9.67M derived: sum of 3 quarters · filed 2024-02-20 | -$132.81M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $14.30M 10-Q · filed 2023-05-09 | $2.34M derived: sum of 2 quarters · filed 2024-02-20 | -$140.14M derived: sum of 3 quarters · filed 2024-02-20 | -$140.08M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | -$11.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$154.44M derived: sum of 2 quarters · filed 2024-02-20 | -$154.38M derived: sum of 3 quarters · filed 2024-02-20 | -$154.19M 10-K · filed 2024-02-20 |
| 2021-09-30 | -$142.48M 10-Q · filed 2022-11-08 | -$142.42M derived: sum of 2 quarters · filed 2022-11-08 | -$142.23M 10-Q · filed 2022-11-08 | -$142.15M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $58.00K 10-Q · filed 2022-08-09 | $249.00K 10-Q · filed 2022-08-09 | $334.00K derived: sum of 3 quarters · filed 2023-02-21 | $397.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $191.00K 10-Q · filed 2022-05-10 | $276.00K derived: sum of 2 quarters · filed 2023-02-21 | $339.00K derived: sum of 3 quarters · filed 2023-02-21 | $397.00K derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $148.00K derived: sum of 2 quarters · filed 2023-02-21 | $206.00K derived: sum of 3 quarters · filed 2023-02-21 | $217.00K 10-K · filed 2023-02-21 |
| 2020-09-30 | $63.00K 10-Q · filed 2021-11-02 | $121.00K derived: sum of 2 quarters · filed 2021-11-02 | $132.00K 10-Q · filed 2021-11-02 | $69.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $58.00K 10-Q · filed 2021-08-09 | $69.00K 10-Q · filed 2021-08-09 | $6.00K derived: sum of 3 quarters · filed 2022-02-22 | $19.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $11.00K 10-Q · filed 2021-05-10 | -$52.00K derived: sum of 2 quarters · filed 2022-02-22 | -$39.00K derived: sum of 3 quarters · filed 2022-02-22 | -$22.00K derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$50.00K derived: sum of 2 quarters · filed 2022-02-22 | -$33.00K derived: sum of 3 quarters · filed 2022-02-22 | -$11.00K 10-K · filed 2022-02-22 |
| 2019-09-30 | $13.00K 10-Q · filed 2020-11-02 | $30.00K derived: sum of 2 quarters · filed 2020-11-02 | $52.00K 10-Q · filed 2020-11-02 | $369.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $17.00K 10-Q · filed 2020-08-10 | $39.00K 10-Q · filed 2020-08-10 | $356.00K derived: sum of 3 quarters · filed 2021-02-23 | $356.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $22.00K 10-Q · filed 2020-05-11 | $339.00K derived: sum of 2 quarters · filed 2021-02-23 | $339.00K derived: sum of 3 quarters · filed 2021-02-23 | $372.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $317.00K derived: sum of 2 quarters · filed 2021-02-23 | $350.00K derived: sum of 3 quarters · filed 2021-02-23 | $537.00K 10-K · filed 2021-02-23 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-12 | $33.00K derived: sum of 2 quarters · filed 2019-11-12 | $220.00K 10-Q · filed 2019-11-12 | -$2.11M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $33.00K 10-Q · filed 2019-08-06 | $220.00K 10-Q · filed 2019-08-06 | -$2.11M derived: sum of 3 quarters · filed 2020-02-24 | -$1.53M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $187.00K 10-Q · filed 2019-05-07 | -$2.14M derived: sum of 2 quarters · filed 2020-02-24 | -$1.56M derived: sum of 3 quarters · filed 2020-02-24 | -$1.38M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | -$2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$1.75M derived: sum of 2 quarters · filed 2020-02-24 | -$1.57M derived: sum of 3 quarters · filed 2020-02-24 | -$1.36M 10-K · filed 2020-02-24 |
| 2017-09-30 | $580.00K 10-Q · filed 2018-11-06 | $760.00K derived: sum of 2 quarters · filed 2018-11-06 | $970.00K 10-Q · filed 2018-11-06 | $548.00K derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-06-30 | $180.00K 10-Q · filed 2018-08-07 | $390.00K 10-Q · filed 2018-08-07 | -$32.00K derived: sum of 3 quarters · filed 2019-02-21 | $1.25M derived: sum of 4 quarters · filed 2019-02-21 |
| 2017-03-31 | $210.00K 10-Q · filed 2018-05-10 | -$212.00K derived: sum of 2 quarters · filed 2019-02-21 | $1.07M derived: sum of 3 quarters · filed 2019-02-21 | $1.37M derived: sum of 4 quarters · filed 2019-02-21 |
| 2016-12-31 | -$422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $862.00K derived: sum of 2 quarters · filed 2019-02-21 | $1.16M derived: sum of 3 quarters · filed 2019-02-21 | $1.16M 10-K · filed 2019-02-21 |
| 2016-09-30 | $1.28M 10-Q · filed 2017-11-07 | $1.58M derived: sum of 2 quarters · filed 2017-11-07 | $1.58M 10-Q · filed 2017-11-07 | $1.58M derived: sum of 4 quarters · filed 2018-02-20 |
| 2016-06-30 | $300.00K 10-Q · filed 2017-08-08 | $300.00K 10-Q · filed 2017-08-08 | $300.00K derived: sum of 3 quarters · filed 2018-02-20 | $300.00K derived: sum of 4 quarters · filed 2018-02-20 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-02-20 | $0.00 derived: sum of 3 quarters · filed 2018-02-20 | $0.00 derived: sum of 4 quarters · filed 2018-02-20 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $0.00 derived: sum of 2 quarters · filed 2018-02-20 | $0.00 derived: sum of 3 quarters · filed 2018-02-20 | $0.00 10-K · filed 2018-02-20 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | ||
| 2014-12-31 | $0.00 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |